Safety of Single-Site Laparoscopic Surgery Requiring Perioperative Heparinization in Colorectal Cancer: Propensity Score-Matched Analysis

Kazuya Iwamoto, Hidekazu Takahashi, Makoto Fujii, Naotsugu Haraguchi, Taishi Hata, Chu Matsuda, Hirofumi Yamamoto, Tsunekazu Mizushima, Masaki Mori, Doki Yuichiro

Research output: Contribution to journalArticle

Abstract

Background: We assessed the feasibility and safety of single-site laparoscopic surgery for patients with colorectal cancer who required perioperative heparinization. Methods: This retrospective study reviewed the medical records of 390 patients who underwent single-site laparoscopic surgery for colorectal cancer from January 2010 to December 2016. Antithrombotic drugs were stopped preoperatively and heparin was administered according to the operative risk of each patient, based on consultation with the cardiologist physician or neurosurgeon. Propensity score modeling was utilized to adjust for baseline characteristics. Results: Of 390 patients, 29 were treated with standard bridging intravenous heparin therapy. Propensity matching identified 119 patients: 22 patients in the heparinization group and 97 in the control group. The matched groups were not significantly different in operation times, bleeding volumes, or conversion rate. The mean postoperative hospital stay was 17.9 days in the heparinization group and 9.5 days in the control group (p = 0.034). Postoperative bleeding was observed in 4 patients (18.2%) in the heparinization group and 11 patients (11.4%) in the control group (p = 0.646), while other complications were similar in the two study groups (p = 0.502). Of these other complications, thromboembolic events were observed in two patients in the heparinization group and one patient in the control group. Conclusions: We found that single-site laparoscopic surgery for colorectal cancer with heparinization was feasible and safe. Heparinization did not increase the risk of postoperative bleeding complications, but postoperative hospital stay was prolonged.

Original languageEnglish
Pages (from-to)4390-4396
Number of pages7
JournalAnnals of Surgical Oncology
Volume26
Issue number13
DOIs
Publication statusPublished - Dec 1 2019

Fingerprint

Propensity Score
Laparoscopy
Colorectal Neoplasms
Safety
Control Groups
Heparin
Length of Stay
Hemorrhage
Bleeding Time
Medical Records
Research Design
Referral and Consultation
Retrospective Studies
Physicians

All Science Journal Classification (ASJC) codes

  • Surgery
  • Oncology

Cite this

Safety of Single-Site Laparoscopic Surgery Requiring Perioperative Heparinization in Colorectal Cancer : Propensity Score-Matched Analysis. / Iwamoto, Kazuya; Takahashi, Hidekazu; Fujii, Makoto; Haraguchi, Naotsugu; Hata, Taishi; Matsuda, Chu; Yamamoto, Hirofumi; Mizushima, Tsunekazu; Mori, Masaki; Yuichiro, Doki.

In: Annals of Surgical Oncology, Vol. 26, No. 13, 01.12.2019, p. 4390-4396.

Research output: Contribution to journalArticle

Iwamoto, K, Takahashi, H, Fujii, M, Haraguchi, N, Hata, T, Matsuda, C, Yamamoto, H, Mizushima, T, Mori, M & Yuichiro, D 2019, 'Safety of Single-Site Laparoscopic Surgery Requiring Perioperative Heparinization in Colorectal Cancer: Propensity Score-Matched Analysis', Annals of Surgical Oncology, vol. 26, no. 13, pp. 4390-4396. https://doi.org/10.1245/s10434-019-07794-x
Iwamoto, Kazuya ; Takahashi, Hidekazu ; Fujii, Makoto ; Haraguchi, Naotsugu ; Hata, Taishi ; Matsuda, Chu ; Yamamoto, Hirofumi ; Mizushima, Tsunekazu ; Mori, Masaki ; Yuichiro, Doki. / Safety of Single-Site Laparoscopic Surgery Requiring Perioperative Heparinization in Colorectal Cancer : Propensity Score-Matched Analysis. In: Annals of Surgical Oncology. 2019 ; Vol. 26, No. 13. pp. 4390-4396.
@article{882bc5a2feb547ffa2ead002cea336f1,
title = "Safety of Single-Site Laparoscopic Surgery Requiring Perioperative Heparinization in Colorectal Cancer: Propensity Score-Matched Analysis",
abstract = "Background: We assessed the feasibility and safety of single-site laparoscopic surgery for patients with colorectal cancer who required perioperative heparinization. Methods: This retrospective study reviewed the medical records of 390 patients who underwent single-site laparoscopic surgery for colorectal cancer from January 2010 to December 2016. Antithrombotic drugs were stopped preoperatively and heparin was administered according to the operative risk of each patient, based on consultation with the cardiologist physician or neurosurgeon. Propensity score modeling was utilized to adjust for baseline characteristics. Results: Of 390 patients, 29 were treated with standard bridging intravenous heparin therapy. Propensity matching identified 119 patients: 22 patients in the heparinization group and 97 in the control group. The matched groups were not significantly different in operation times, bleeding volumes, or conversion rate. The mean postoperative hospital stay was 17.9 days in the heparinization group and 9.5 days in the control group (p = 0.034). Postoperative bleeding was observed in 4 patients (18.2{\%}) in the heparinization group and 11 patients (11.4{\%}) in the control group (p = 0.646), while other complications were similar in the two study groups (p = 0.502). Of these other complications, thromboembolic events were observed in two patients in the heparinization group and one patient in the control group. Conclusions: We found that single-site laparoscopic surgery for colorectal cancer with heparinization was feasible and safe. Heparinization did not increase the risk of postoperative bleeding complications, but postoperative hospital stay was prolonged.",
author = "Kazuya Iwamoto and Hidekazu Takahashi and Makoto Fujii and Naotsugu Haraguchi and Taishi Hata and Chu Matsuda and Hirofumi Yamamoto and Tsunekazu Mizushima and Masaki Mori and Doki Yuichiro",
year = "2019",
month = "12",
day = "1",
doi = "10.1245/s10434-019-07794-x",
language = "English",
volume = "26",
pages = "4390--4396",
journal = "Annals of Surgical Oncology",
issn = "1068-9265",
publisher = "Springer New York",
number = "13",

}

TY - JOUR

T1 - Safety of Single-Site Laparoscopic Surgery Requiring Perioperative Heparinization in Colorectal Cancer

T2 - Propensity Score-Matched Analysis

AU - Iwamoto, Kazuya

AU - Takahashi, Hidekazu

AU - Fujii, Makoto

AU - Haraguchi, Naotsugu

AU - Hata, Taishi

AU - Matsuda, Chu

AU - Yamamoto, Hirofumi

AU - Mizushima, Tsunekazu

AU - Mori, Masaki

AU - Yuichiro, Doki

PY - 2019/12/1

Y1 - 2019/12/1

N2 - Background: We assessed the feasibility and safety of single-site laparoscopic surgery for patients with colorectal cancer who required perioperative heparinization. Methods: This retrospective study reviewed the medical records of 390 patients who underwent single-site laparoscopic surgery for colorectal cancer from January 2010 to December 2016. Antithrombotic drugs were stopped preoperatively and heparin was administered according to the operative risk of each patient, based on consultation with the cardiologist physician or neurosurgeon. Propensity score modeling was utilized to adjust for baseline characteristics. Results: Of 390 patients, 29 were treated with standard bridging intravenous heparin therapy. Propensity matching identified 119 patients: 22 patients in the heparinization group and 97 in the control group. The matched groups were not significantly different in operation times, bleeding volumes, or conversion rate. The mean postoperative hospital stay was 17.9 days in the heparinization group and 9.5 days in the control group (p = 0.034). Postoperative bleeding was observed in 4 patients (18.2%) in the heparinization group and 11 patients (11.4%) in the control group (p = 0.646), while other complications were similar in the two study groups (p = 0.502). Of these other complications, thromboembolic events were observed in two patients in the heparinization group and one patient in the control group. Conclusions: We found that single-site laparoscopic surgery for colorectal cancer with heparinization was feasible and safe. Heparinization did not increase the risk of postoperative bleeding complications, but postoperative hospital stay was prolonged.

AB - Background: We assessed the feasibility and safety of single-site laparoscopic surgery for patients with colorectal cancer who required perioperative heparinization. Methods: This retrospective study reviewed the medical records of 390 patients who underwent single-site laparoscopic surgery for colorectal cancer from January 2010 to December 2016. Antithrombotic drugs were stopped preoperatively and heparin was administered according to the operative risk of each patient, based on consultation with the cardiologist physician or neurosurgeon. Propensity score modeling was utilized to adjust for baseline characteristics. Results: Of 390 patients, 29 were treated with standard bridging intravenous heparin therapy. Propensity matching identified 119 patients: 22 patients in the heparinization group and 97 in the control group. The matched groups were not significantly different in operation times, bleeding volumes, or conversion rate. The mean postoperative hospital stay was 17.9 days in the heparinization group and 9.5 days in the control group (p = 0.034). Postoperative bleeding was observed in 4 patients (18.2%) in the heparinization group and 11 patients (11.4%) in the control group (p = 0.646), while other complications were similar in the two study groups (p = 0.502). Of these other complications, thromboembolic events were observed in two patients in the heparinization group and one patient in the control group. Conclusions: We found that single-site laparoscopic surgery for colorectal cancer with heparinization was feasible and safe. Heparinization did not increase the risk of postoperative bleeding complications, but postoperative hospital stay was prolonged.

UR - http://www.scopus.com/inward/record.url?scp=85073963926&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85073963926&partnerID=8YFLogxK

U2 - 10.1245/s10434-019-07794-x

DO - 10.1245/s10434-019-07794-x

M3 - Article

C2 - 31493124

AN - SCOPUS:85073963926

VL - 26

SP - 4390

EP - 4396

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

SN - 1068-9265

IS - 13

ER -